Double Medical Technology Hits Day Low at CNY 42.99 Amid Price Pressure

Double Medical Technology, Inc. experienced a notable decline today, with its stock price dropping by 3.74% as it reached an intraday low of CNY 42.99. This performance comes amid a broader market context, where the China Shanghai Composite index fell by 1.39% on the same day. Over the past week, Double Medical has seen a decrease of 4.57%, and its monthly performance reflects a decline of 9.03%. Year-to-date, the stock has faced challenges, with a drop of 8.78%, contrasting with the slight gain of 0.95% in the China Shanghai Composite. However, on a yearly basis, Double Medical has shown resilience, boasting a return of 30.54%, significantly outperforming the market's 16.93%. Despite today's downturn, the company has reported strong financial metrics, including a net profit growth of 27.79% and a robust operating cash flow of CNY 710.24 million. With a market capitalization of CNY 16,653 million, Double Medical continues to maintain a solid position within the pharmaceuticals and biotechnology industry.